Wedbush initiated coverage of Tourmaline Bio (TRML) with an Outperform rating and $42 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRML:
Questions or Comments about the article? Write to editor@tipranks.com